These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28053502)

  • 1. Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome.
    Chung WH; van Dijk EH; Mohabati D; Dijkman G; Yzer S; de Jong EK; Fauser S; Schlingemann RO; Hoyng CB; Boon CJ
    Clin Ophthalmol; 2017; 11():63-70. PubMed ID: 28053502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics of Neovascular Age-Related Macular Degeneration without Typical Drusen.
    Kamao H; Goto K; Matsuno K; Mizukawa K; Miki A; Kiryu J
    J Ophthalmol; 2021; 2021():6683532. PubMed ID: 33996151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy.
    Zhou H; Zhao X; Wang S; Chen Y
    Ophthalmol Ther; 2023 Apr; 12(2):827-837. PubMed ID: 36539596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Age-Related Macular Degeneration (AMD) in the Fellow Eye of Patients with AMD Treated by Treat-and-Extend Intravitreal Therapy with Aflibercept.
    Mimura K; Matsumoto H; Morimoto M; Akiyama H
    Ophthalmologica; 2018; 239(2-3):121-127. PubMed ID: 29169154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
    Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
    Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Zhao X; Meng L; Luo M; Yu W; Min H; Dai R; Koh A; Chen Y
    Ther Adv Chronic Dis; 2021; 12():20406223211026389. PubMed ID: 34221305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P; van den Bergh H; Sickenberg M; Koh AH
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
    Spielberg L; Leys A
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration.
    Beck M; Munk MR; Ebneter A; Wolf S; Zinkernagel MS
    Am J Ophthalmol; 2016 Jul; 167():10-7. PubMed ID: 27084000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Mao J; Chen N; Zhang S; Fang Y; Zheng Z; Wu S; Ye X; Chen Y; Chen Y; Shen L
    Front Med (Lausanne); 2022; 9():973025. PubMed ID: 36213652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neovascularization in Fellow Eye of Unilateral Neovascular Age-related Macular Degeneration According to Different Drusen Types.
    Lee J; Choi S; Lee CS; Kim M; Kim SS; Koh HJ; Lee SC; Byeon SH
    Am J Ophthalmol; 2019 Dec; 208():103-110. PubMed ID: 31377285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic.
    Nemcansky J; Stepanov A; Koubek M; Veith M; Klimesova YM; Studnicka J
    J Ophthalmol; 2019; 2019():2635689. PubMed ID: 31316822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P; Anantharaman G; Gopalakrishnan M; Goyal A
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration.
    Zhu M; Wijeyakumar W; Syed AR; Joachim N; Hong T; Broadhead GK; Li H; Luo K; Chang A
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):475-484. PubMed ID: 27572301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.
    Friberg TR; Musch DC; Lim JI; Morse L; Freeman W; Sinclair S;
    Ophthalmology; 2006 Apr; 113(4):622.e1. PubMed ID: 16581422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 8-year follow-up of anti-vascular endothelial growth factor treatment with a treat-and-extend modality for neovascular age-related macular degeneration.
    Berg K; Roald AB; Navaratnam J; Bragadóttir R
    Acta Ophthalmol; 2017 Dec; 95(8):796-802. PubMed ID: 28926190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up.
    Inan S; Baysal Z; Inan UU
    Curr Eye Res; 2019 Aug; 44(8):908-915. PubMed ID: 30909756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.